Cargando…
Resistance of mitochondrial p53 to dominant inhibition
BACKGROUND: Mutation of a tumor suppressor allele leaves the second as backup. Not necessarily so with p53. This homo-tetrameric transcription factor can become contaminated with mutant p53 through hetero-tetramerization. In addition, it can be out-competed by the binding to p53 DNA recognition moti...
Autores principales: | Heyne, Kristina, Schmitt, Katrin, Mueller, Daniel, Armbruester, Vivienne, Mestres, Pedro, Roemer, Klaus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440547/ https://www.ncbi.nlm.nih.gov/pubmed/18547443 http://dx.doi.org/10.1186/1476-4598-7-54 |
Ejemplares similares
-
Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
por: Heyne, Kristina, et al.
Publicado: (2014) -
Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling
por: Reichrath, Jörg, et al.
Publicado: (2014) -
NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle
por: Heyne, Kristina, et al.
Publicado: (2010) -
HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues
por: Schmitt, Katja, et al.
Publicado: (2015) -
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)